Loss Of Central ICL Vaulting Associated With Anterior Subcapsular Cataract In Myopes

Monday, August 23, 2010

Comments

Ocular Surgery News

Central vaulting of a posterior chamber phakic IOL diminished steadily for up to 10 years, a study found. In addition, the investigators reported a significant link between insufficient ICL vaulting and the development of anterior subcapsular cataract.

Full Story

Cataract Products and Equipment »

Which of the following treatments is FDA approved for the treatment of postoperative pseudophakic cystoid macular edema (Irvine-Gass syndrome)?
1. Topical prednisolone acetate 1% (PredForte) QID
2. Topical ketorolac tromethamine (Acular) QID
3. Topical nepefanac (Nevanac) TID
4. Intravitreal triamcinolone acetonide(Kenalog) in 0.1 cc
5. None of the above
Check The Answer

OPMI LUMERA 700 Surgical Microscope
OPMI LUMERA 700 Incorporating the latest... view product
Selecta Trio™ YAG Laser, SLT and Photocoagulation
The Lumenis Selecta® Trio™ ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Loss Of Central ICL Vaulting Associated With Anterior Subcapsular Cataract In Myopes

Comments

Related Categories

Cataract Products and Equipment »

Quick Quiz

Which of the following treatments is FDA approved for the treatment of postoperative pseudophakic cystoid macular edema (Irvine-Gass syndrome)?

AdGlare RMR Ad

Cataract Featured Products

OPMI LUMERA 700 Surgical Microscope

Selecta Trio™ YAG Laser, SLT and Photocoagulation

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us